List view / Grid view
4 November 2014 | By Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited have announced that Marc Princen joined Takeda Pharmaceuticals International GmbH as Corporate Officer and President of the EUCAN (Europe and Canada) Business Unit...
22 October 2014 | By Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc
Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc. presented new evidence supporting the use of Latuda® (lurasidone), an atypical antipsychotic treatment for adults with schizophrenia, during multiple poster sessions at the 27th European College of Neuropsychopharmacology...
4 December 2013 | By Teva Pharmaceutical Industries
Glatiramer acetate for injection is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis...
27 September 2013 | By Takeda Pharmaceutical Company Limited
TAK-816 is a Haemophilus Influenzae type b (Hib) vaccine...
24 September 2013 | By Takeda
Authorisation received for VipidiaTM (alogliptin) and Fixed-Dose Combinations VipdometTM (alogliptin and metformin) and IncresyncTM (alogliptin and pioglitazone)...
6 September 2013 | By Takeda
FDA has granted Priority Review status for the Biologics License Application (BLA) for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis...
26 July 2013 | By Virgo Health
“The number of people at risk from complications associated with type 2 diabetes continues to rise..."
16 July 2013 | By Pfizer Inc.
Pfizer provides update on XELJANZ® (tofacitinib citrate) for the treatment of rheumatoid arthritis...
21 March 2013 | By Takeda Pharmaceuticals International GmbH (Takeda)
Takeda announced further expansion of its presence in Latin America with the launch of its wholly-owned subsidiary in Ecuador...
6 November 2012 | By
Gains innovative research platform-bacTRAP technology and adds novel CNS programs...
4 September 2012 | By F T I Consulting
The European Commission has granted European market authorization for the medicinal product teduglutide...
23 April 2012 | By Takeda Pharmaceutical Company Limited
For the treatment of iron deficiency anaemia in adult chronic kidney disease patients...
19 March 2012 | By Takeda Pharmaceutical Company Limited
Results presented at 76th Annual Scientific Meeting of the Japanese Circulation Society in Fukuoka...
27 February 2012 | By Weber Shandwick
An investigational compound for the treatment of anemia associated with CKD...
8 December 2011 | By Virgo HEALTH
The European Commission has granted marketing authorisation for Edarbi® (azilsartan medoxomil)...
